Publication | Closed Access

Rosuvastatin improves olanzapine’s effects on behavioral impairment and hippocampal, hepatic and metabolic damages in isolated reared male rats

Metabolic DamagesMolecular PharmacologyPsychoactive DrugBehavioral NeuroscienceMedicinePsychotropic MedicationBehavioral PharmacologyBehavioural PharmacologyPsychopharmacologyNeuropharmacologyExperimental PharmacologyPharmacotherapyNeurosciencePharmacologyBehavioral ImpairmentSocial Sciences